If you work in a hospital these days, you've probably gotten the invitation: Take a survey about how well you, your team and your hospital do at protecting patients from harm, and how empowered you feel to do the right thing.
Jun 3, 2016
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation. In a ...
Jun 3, 2016
Empagliflozin (trade name: Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. In 2014, the German Institute for ...
Jun 3, 2016
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours. This aims to slow the growth of the tumours. The German ...
Jun 3, 2016
Moffitt Cancer Center will present results of the phase 3 NETTER-1 study, showing clinically meaningful and significant results for Lutathera (77Lu-DOTA0-Tyr3-Octreotate) in patients with metastatic midgut neuroendocrine ...
Jun 3, 2016
In 2014, before the FIFA World Cup opened in Brazil, there were fears that many of the 600,000 foreign visitors expected for the world's largest soccer tournament would acquire dengue fever. Their numbers could reach hundreds ...
Jun 3, 2016
